Petter Brandal

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 9

Top Topics

Magnetic Resonance

Top Venues

Neuro-oncology practice

Neuro-oncology advances

This page only lists publications with an associated author ORCID identifier.

Publications

Yeva Prysiazhniuk, Andres Server Alonso, Henning Leske, Øystein Bech-Aase, Eirik Helseth, Roelant Sjouke Eijgelaar, Elies Fuster-Garcia, Petter Brandal, Atle Bjørnerud, Jakub Otáhal, Jan Petr, Wibeke Nordhøy
Diffuse glioma molecular profiling with arterial spin labeling and dynamic susceptibility contrast perfusion MRI: A comparative study. Neuro-oncology advances 6 (1) (2024)
Emeline Tabouret, Julia Furtner, Thomas Graillon, Antonio Silvani, Emilie Le Rhun, Riccardo Soffietti, Giuseppe Lombardi, Juan Manuel Sepúlveda-Sánchez, Petter Brandal, Martin Bendszus, Vassilis Golfinopoulos, Thierry Gorlia, Michael Weller, Felix Sahm, Wolfgang Wick, Matthias Preusser
3D volume growth rate evaluation in the EORTC-BTG-1320 clinical trial for recurrent WHO grade 2 and 3 meningiomas. Neuro-oncology 26 (7) (2024)
Emeline Tabouret, Julia Furtner, Thomas Graillon, Antonio Silvani, Emilie Le Rhun, Riccardo Soffietti, Giuseppe Lombardi, Juan Manuel Sepúlveda-Sánchez, Petter Brandal, Martin Bendszus, Vassilis Golfinopoulos, Thierry Gorlia, Michael Weller, Felix Sahm, Wolfgang Wick, Matthias Preusser
3D volume growth rate evaluation in the EORTC-BTG-1320 clinical trial for recurrent WHO grade 2 and 3 meningiomas. Neuro-oncology 26 (7) (2024)
Emeline Tabouret, Julia Furtner, Thomas Graillon, Antonio Silvani, Emilie Le Rhun, Riccardo Soffietti, Giuseppe Lombardi, Juan Manuel Sepúlveda-Sánchez, Petter Brandal, Martin Bendszus, Vassilis Golfinopoulos, Thierry Gorlia, Michael Weller, Felix Sahm, Wolfgang Wick, Matthias Preusser
3D volume growth rate evaluation in the EORTC-BTG-1320 clinical trial for recurrent WHO grade 2 and 3 meningiomas. Neuro-oncology 26 (7) (2024)
Yeva Prysiazhniuk, Andres Server Alonso, Henning Leske, Øystein Bech-Aase, Eirik Helseth, Roelant Sjouke Eijgelaar, Elies Fuster-Garcia, Petter Brandal, Atle Bjørnerud, Jakub Otáhal, Jan Petr, Wibeke Nordhøy
Diffuse glioma molecular profiling with arterial spin labeling and dynamic susceptibility contrast perfusion MRI: A comparative study. Neuro-oncology advances 6 (1) (2024)
Emeline Tabouret, Julia Furtner, Thomas Graillon, Antonio Silvani, Emilie Le Rhun, Riccardo Soffietti, Giuseppe Lombardi, Juan Manuel Sepúlveda-Sánchez, Petter Brandal, Martin Bendszus, Vassilis Golfinopoulos, Thierry Gorlia, Michael Weller, Felix Sahm, Wolfgang Wick, Matthias Preusser
3D volume growth rate evaluation in the EORTC-BTG-1320 clinical trial for recurrent WHO grade 2 and 3 meningiomas. Neuro-oncology 26 (7) (2024)
Hanne Blakstad, Eduardo Erasmo Mendoza Mireles, Liv Cathrine Heggebø, Henriette Magelssen, Mette Sprauten, Tom Børge Johannesen, Einar Osland Vik-Mo, Henning Leske, Pitt Niehusmann, Karoline Skogen, Eirik Helseth, Kyrre Eeg Emblem, Petter Brandal
Incidence and outcome of pseudoprogression after radiation therapy in glioblastoma patients: A cohort study. Neuro-oncology practice 11 (1) (2023)
Hanne Blakstad, Eduardo Erasmo Mendoza Mireles, Liv Cathrine Heggebø, Henriette Magelssen, Mette Sprauten, Tom Børge Johannesen, Einar Osland Vik-Mo, Henning Leske, Pitt Niehusmann, Karoline Skogen, Eirik Helseth, Kyrre Eeg Emblem, Petter Brandal
Incidence and outcome of pseudoprogression after radiation therapy in glioblastoma patients: A cohort study. Neuro-oncology practice 11 (1) (2023)
Eduardo Erasmo Mendoza Mireles, Erlend Skaga, Andres Server Alonso, Henning Leske, Petter Brandal, Eirik Helseth, Pål A Rønning, Einar Osland Vik-Mo
The benefit of complete resection of contrast enhancing tumor in glioblastoma patients: A population-based study. Neuro-oncology practice 10 (6) (2023)